Condensed Statements of Cash Flows (USD $)	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash Flows From Operating Activities
Net loss from continuing operations	$ (4,322,972)	$ (35,143)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Depreciation and amortization	291,129	281,279
Non-cash interest relating to convertible debt and loan cost amortization	217,290	1,053,450
Non-cash compensation relating to business combination	4,418,524	0
Changes in operating assets and liabilities, net of those acquired in business combination:
Accounts receivable	(995,105)	(32,061)
Inventories	224,999	(587,559)
Prepaid expenses	140,688	29,549
Accounts payable	(358,779)	69,863
Accrued expenses, returned goods reserve and deferred revenue	(599,386)	(172,926)
Net Cash and Cash Equivalents (Used in)/Provided by Continuing Operations	(983,612)	606,452
Net Cash Used in Discontinued Operation	(4,376)	(50,554)
Net Cash and Cash Equivalents (Used in)/Provided by Operating Activities	(987,988)	555,898
Cash Flows From Investing Activities
Cash acquired in business combination	18,197,442	0
Acquisition of property and equipment, net of disposals	(127,686)	(69,096)
Net Cash and Cash Equivalents Provided by/(Used in) Investing Activities	18,069,756	(69,096)
Cash Flows From Financing Activities
(Repayments)/borrowings under line of credit, net	(4,065,307)	193,566
Payment of debt issuance costs	0	(260,748)
Treasury stock purchases	(432,562)	0
Net Cash and Cash Equivalents Used in Continuing Operations	(4,497,869)	(67,182)
Net Cash Used in Discontinued Operation	0	(300,000)
Net Cash and Cash Equivalents Used in Financing Activities	(4,497,869)	(367,182)
Change in Cash and Cash Equivalents	12,583,899	119,620
Cash and cash equivalents, beginning of period	11,028	0
Cash and cash equivalents, end of period	12,594,927	119,620
Supplemental disclosure for cash flow information:
Cash paid for interest	249,612	104,462
Supplemental non-cash investing and financing activities:
Issuance Of Common Stock In Business Combination	40,033,695	0
Exchange of Series D, Series C, Series B, Series A, and common stock	57,296,106	0
Acquired intangibles	10,900,000	0
Acquired goodwill	1,838,309	0
Acquired restricted cash	2,260,100	0
Other acquired tangible assets	79,261	0
Assumed liabilities	3,479,979	0
Preferred stock dividends	4,974,199	1,799,057
Issuance of common and preferred stock upon cashless warrant exercise	0	4,984
Issuance of preferred stock upon convertible debt conversion	$ 0	$ 17,609,646